L. Ostios

What do we know about cancer immunotherapy? Long-term survival and immune-related adverse events

Mir, J. Villamayor, L. Ostios, 2017 .

Prognostic value of neutrophil-to-lymphocyte ratio in advanced cancer patients receiving immunotherapy

E. Espinosa, J. Feliu, Á. Pinto, 2020, Clinical and Translational Oncology.

Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years’ experience of a reference centre in Spain

M. del Río, R. D. de Lucas, B. Castelo, 2019, Clinical and Translational Oncology.